CORD Submits to House Health Committee “Value-Based” Approach for Access to Essential Drugs for Rare Diseases
As the House of Commons Standing Committee on Health wraps up two-months of testimonials from dozens of witnesses including individual patients, clinicians, researchers, bureaucrats, and pharmaceutical companies, the Canadian Organization for Rare Disorders submitted a comprehensive proposal for assuring all Canadians with rare disorders have timely and appropriate access to necessary medicines.